GRP
TVTX icon

Global Retirement Partners’s Travere Therapeutics TVTX Stock Holding History

Global Retirement Partners’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.25K Buy
+85
New +$2.76K ﹤0.01% 3573
2024
Q2 		– Sell
-19
Closed -$146 – 3643
2024
Q1 		$146 Hold
19
– – ﹤0.01% 3280
2023
Q4 		$169 Buy
+19
New +$138 ﹤0.01% 3241

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Global Retirement Partners's TVTX Position: Q4 2025 in Review

Global Retirement Partners opened a new position in Travere Therapeutics (TVTX) in Q4 2025: 85 shares worth $3.25K. The stake represents ﹤0.01% of the portfolio and ranks #3573 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in TVTX as recently as Q1 2024.

Global Retirement Partners first reported a position in TVTX in Q4 2023 and has held it in 3 quarters since. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.

  • Global Retirement Partners held 85 shares of Travere Therapeutics worth $3.25K as of Q4 2025.
  • Travere Therapeutics was a new Global Retirement Partners position in Q4 2025.
  • Travere Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3573 holding.
  • Global Retirement Partners first reported a position in Travere Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • 278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.